We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Next-Generation Sequencing – News and Features

News

Global Network to Provide More Scientists Access to Illumina's Sequencing Technology

Creation of the Illumina Genome Network will link researchers interested in conducting large-scale whole human genome sequencing projects using Illumina sequencing.
News

CMS Approves Clinical Study of Genetic Test to Predict Patient Response to Warfarin

Study to evaluate gene identification ability to predict patient response and improve safety when dosing this anti-blood clotting drug.
News

Leading Agricultural Institute Reports Robust Genetic Analysis Results from Fluidigm Biomark™ System

INRA core facility is now providing a wide range of services on a Fluidigm BioMark™ System for Genetic Analysis to all European researchers.
News

Eurofins MWG Operon and Genomatix Developed Complete Human Exome Array

Joint services offered for human exome targeted re-sequencing based on Roche NimbleGen format.
News

U.S. and Norwegian Scientists Use 454 Sequencing Systems to Identify a Virus Threatening Farmed and Wild Salmon

Study sheds new light onto the mysterious disease which has cause widespread damage to farmed salmon populations.
News

Agilent Selects SeqWright as First Target Enrichment Certified Service Provider for AB SOLiD Sequencing

SeqWright system offers optimized protocols for the Illumina Genome Analyzer and Life Technologies’ AB SOLiD platforms.
News

Ariadne to Collaborate in €7.5M Neuromuscular Disease Consortium to Find Biomarkers

The new collaboration with the BIO-NMD consortium is aimed at identifying non-invasive biomarkers for monitoring neuromuscular diseases.
News

Roche and IBM Collaborate to Develop Nanopore-Based DNA Sequencing Technology

Collaboration aims to accelerate human genome analysis and enable advancements in personalized healthcare.
News

TriLink Awarded SBIR Phase II Grant: Chemical Determinants of DNA Ligase Fidelity

The National Institutes of Health recently awarded TriLink BioTechnologies, Inc. (TriLink) a Phase II SBIR Grant of approximately $725,000 to continue their work on developing reagents to enhance the specificity of DNA ligase.
News

1000 Genomes Project Releases Data from Pilot Projects on Path to Providing Database for 2,500 Human Genomes

Freely available data supporting next generation of human genetic research.
Advertisement